{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:53:16Z","timestamp":1772517196529,"version":"3.50.1"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,10,10]]},"DOI":"10.1001\/jama.2023.18508","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:30:37Z","timestamp":1694431837000},"page":"1335","source":"Crossref","is-referenced-by-count":5,"title":["Gefapixant for Refractory or Unexplained Chronic Cough?"],"prefix":"10.1001","volume":"330","author":[{"given":"Richard S.","family":"Irwin","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Mark","family":"Madison","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"jed230075r1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18035","article-title":"Efficacy and tolerability of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis.","author":"Kum","year":"2023","journal-title":"JAMA"},{"issue":"pt 1","key":"jed230075r2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1113\/jphysiol.1996.sp021142","article-title":"Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals.","volume":"490","author":"Pelleg","year":"1996","journal-title":"J Physiol"},{"issue":"5","key":"jed230075r3","doi-asserted-by":"publisher","first-page":"L858","DOI":"10.1152\/ajplung.90360.2008","article-title":"P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus.","volume":"295","author":"Kwong","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"pt 3","key":"jed230075r4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.pupt.2019.03.007","article-title":"Subtypes of vagal afferent C-fibres in guinea-pig lungs.","volume":"556","author":"Undem","year":"2004","journal-title":"J Physiol"},{"issue":"6","key":"jed230075r5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00408-022-00587-2","article-title":"Validation and meaningful change thresholds for an objective cough frequency measurement in chronic cough.","volume":"200","author":"Schelfhout","year":"2022","journal-title":"Lung"},{"key":"jed230075r6","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211049743","article-title":"Validation of a visual analog scale for assessing cough severity in patients with chronic cough.","volume":"15","author":"Martin Nguyen","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"jed230075r7","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221099737","article-title":"Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough.","volume":"16","author":"Nguyen","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"jed230075r8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"10328","key":"jed230075r9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2).","volume":"399","author":"McGarvey","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"jed230075r10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1164\/rccm.202211-2128LE","article-title":"Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks.","volume":"207","author":"Birring","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"jed230075r11","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1007\/s00408-009-9173-3","article-title":"Importance of placebo effect in cough clinical trials.","volume":"188","author":"Eccles","year":"2010","journal-title":"Lung"},{"issue":"5","key":"jed230075r12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1258\/jrsm.2008.070466","article-title":"The power of context: reconceptualizing the placebo effect.","volume":"101","author":"Miller","year":"2008","journal-title":"J R Soc Med"},{"issue":"4","key":"jed230075r13","doi-asserted-by":"publisher","first-page":"00284","DOI":"10.1183\/23120541.00284-2020","article-title":"Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough.","volume":"6","author":"Muccino","year":"2020","journal-title":"ERJ Open Res"},{"key":"jed230075r14","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1378\/chest.129.1_suppl.1S","article-title":"Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines.","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"issue":"1","key":"jed230075r15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1378\/chest.15-0164","article-title":"Assessment of intervention fidelity and recommendations for researchers conducting studies on the diagnosis and treatment of chronic cough in the adult: CHEST guideline and expert panel report.","volume":"148","author":"French","year":"2015","journal-title":"Chest"},{"issue":"6","key":"jed230075r16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.chest.2016.08.1458","article-title":"Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report.","volume":"150","author":"Kahrilas","year":"2016","journal-title":"Chest"},{"issue":"1","key":"jed230075r17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chest.2017.10.016","article-title":"Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report.","volume":"153","author":"Irwin","year":"2018","journal-title":"Chest"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2809600\/jama_irwin_2023_ed_230075_1696345537.04582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:06:48Z","timestamp":1696950408000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2809600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":17,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.18508","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}